The Network

The NSW Stem Cell Network is a professional community with an interest in all forms of stem cells.

The Network strategy is to work with the scientific, health and medical research communities, the higher education sector and business to promote growth and innovation to achieve positive outcomes for the people of NSW. Our work encompasses science, medicine, ethics, law, business and public awareness of stem cells.


The Network, since its establishment in 2002, has worked towards:

  • Facilitating communication among members to promote the use of stem cells within an ethical framework;
  • Acting as a source of information on stem cells for the community and as a public advocate for them;
  • Promoting the development of resources to support the use of stem cells within New South Wales;
  • Enhancing the R&D and/or commercialisation potential of stem cells within New South Wales.

How do we work?

The Network pursues its goals by regularly conducting workshops, seminars, conferences and courses that allow the sharing of knowledge and professional skills as well as embarking on collaborative research and commercial initiatives.


The NSW Stem Cell Network receives financial support from the NSW Government Office for Health and Medical Research; and infrastructure support from Diabetes New South Wales.

How to become a member?

To keep up to date with the latest news from the Network complete the membership form.

Who is in the Network?

The NSW Stem Cell Network members come from a variety of areas, including:

  • Heads of Research Institutes
  • Senior Research Scientists
  • Biotechnology Companies
  • Embryologists
  • Clinicians
  • Bioethicists
  • Lawyers
  • Policy Advisors
  • State and Federal Health
  • University Academics
  • PhD/ Research Students
  • Nurses/Physiotherapists
  • Science Communicators
  • Scientific Supplies
  • Pharmaceutical Companies

NSW Stem Cell Network brochure










Executive Committee

Professor Bernie Tuch
Bernie Tuch is Director of the NSW Stem Cell Network, and an endocrinologist. In the 1980's, Dr Tuch was in charge of the Australian group that first transplanted human fetal pancreatic tissue into people with type 1 diabetes. In 2006, he and colleagues conducted another Diabetes Therapy Trial, with insulin-producing cells derived from human donors after their death. The cells were placed in immunoisolating microcapsules made from alginate, a product from seaweed. Around the same time, and with support from the NHMRC Embryo Licensing Committee, he and colleagues made 2 new human embryonic stem cell lines, called Endeavour-1 and Endeavour-2. It is these cells, differentiated into insulin-producing cells, which he is hoping will be encapsulated and used in a 3rd Diabetes Therapy Trial.
Joanna Knott
Joanna Knott is a co-founder (20 years ago) and the Chair of national research charity, SpinalCure Australia. She has a 25-year career in Communications/PR. Her work was a major contributor to Federal Parliamentarians voting in favour of this research in a conscience vote in 2006. In 2008, she was awarded an OAM for her work in this sector.
Dr Daniella Goldberg
Daniella Goldberg embarked on her career in medical research twenty years ago and in the late 1990's she moved into science communications producing educational science programs for radio and TV and publishing newspapers and magazines such as Australian Biotechnology News. Daniella joined the Diabetes Transplant Unit in 2002 and later that year set up the NSW Stem Cell Network with Prof Bernie Tuch.
Dr Kelvin Hopper
Kelvin Hopper has extensive experience as a medical researcher and in the biotech and medtech industry. He is Chairman of the corporate advisory company Aoris Nova Pty. Ltd. and is a founder and Director of BioFusion Capital Pty Ltd. He has strong interest in the development and application of cell and tissue therapies, particularly stem cells.
Prof Ian Kerridge
Ian Kerridge is Director and Associate Professor in Bioethics at the Centre for Values, Ethics and the Law in Medicine at the University of Sydney and Staff Haematologist/Bone Marrow Transplant physician at Westmead Hospital, Sydney. He is Chair of the Australian Bone Marrow Donor Registry Ethics Committee and a member of the NSW Health Department’s Clinical Ethics Advisory Panel. In 2005 Ian was a member of the Legislation Review Committee (Lockhart Committee) which reviewed the Prohibition of Human Cloning Act 2002 and the Research Involving Human Embryos Act 2002.
Dr Michael Morris
Michael Morris specialises in research on embryonic stem cells and embryology, with a view to understanding normal and abnormal nervous system development and improving the viability of embryos for IVF. He worked in embryonic stem-cell R&D in the biotech industry and the Australian Stem Cell Centre before moving to an academic position at Sydney University. He is a member of the Kolling Institute of Medical Research and the Bosch Institute, and is a founding member of the Sydney Centre for Developmental and Regenerative Medicine.
Dr Rachel Shparberg
Rachel Shparberg completed her PhD at The University of Sydney in 2018. Her research focused on understanding the mechanisms underlying mammalian nervous system development using mouse embryonic stem cells. Rachel has held teaching roles at The University of Sydney since 2013 and worked as the part-time Manager of The NSW Stem Cell Network in 2015. Following the completion of her PhD, Rachel worked as a Clinical Research Scientist in a pain clinic, and currently works with human embryonic stem cells to understand lens development and disease.





















































Free Counter
Free Counter